Medical Illustrations 3D Medical Animation

Major Funding Awarded To Improve Treatment Of Drug-Resistant Tuberculosis And HIV Co-infection
For the third time in four months, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a research grant aimed at helping people infected with multidrug-resistant tuberculosis (MDR-TB). Taken together, all three NIH grants total $8.57 million...

Study Of Infections Associated With Eczema
The National Institute of Allergy and Infections Disease has awarded a five-year $31 million contract to National Jewish Health, which is leading a consortium of academic medical centers seeking to better understand skin infections associated with atopic dermatitis...

Seegene Introduces First Real-time Molecular Diagnostic Test For Tuberculosis And Multi-drug Resistant Tuberculosis
The emergence and spread of drug-resistant mycobacterium tuberculosis (TB) threatens global TB control efforts, and there is an urgent need for new diagnostic tests that rapidly identify drug sensitivity profiles of TB strains...

MRSA's Next Move Predicted By Computer Program
Researchers at Duke University Medical Center are using computers to identify how one strain of dangerous bacteria might mutate in the same way a champion chess player tries to anticipate an opponent's strategies. The predictive software could result in better drug design to beat antibiotic-resistant mutations...

Cubist Announces Objectives Met In Phase 2 Safety Study Of CUBICIN In Prosthetic Joint Infections
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST), a leading acute care therapeutics company, announced that its Phase 2 safety study of CUBICIN® (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives...

Universal Surveillance For MRSA Significantly Decreased HAIs At PCMH
Pitt County Memorial Hospital (PCMH) has announced results of a study demonstrating that universal surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreased health care-associated infections (HAIs) related to devices...

Alarming Infection Outbreak Halted By Prompt Actions At Dallas Hospital
Rapid identification and aggressive infection control measures allowed a Dallas hospital to stop the spread of Acinetobacter baumannii, a type of bacteria that has become increasingly prevalent in healthcare facilities and is resistant to most antibiotics...

Antibiotics Should Be Assigned To A Special Drug Class To Preserve Their Power, Says Alliance For The Prudent Use Of Antibiotics
To preserve their power to treat infections, antibiotics should be assigned to a special drug class, Stuart B. Levy, president of the Alliance for the Prudent Use of Antibiotics (APUA), the leading, independent global organization dedicated to preserving the power of antibiotics, told a gathering of scientists meeting yesterday at the International Conference on Emerging Infectious Diseases...

A Step Closer To The Development Of A New Clinically Useful Antibiotic
Scientists have identified the genes necessary for making a highly potent and clinically unexploited antibiotic in the fight against multi-resistant pathogens...

New Research Uncovers Why Many With Lupus Are Resistant To Traditional Treatments
Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today. It is estimated that more than 5 million people suffer from lupus worldwide...

Scientists Demonstrate Antifungal Properties Of Vitamin B3
A team of scientists from the Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal have identified vitamin B3 as a potential antifungal treatment...

FDA Clears Roche's LightCycler(R) MRSA Advanced Test For Use In The U.S.
Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food & Drug Administration (FDA) cleared its new LightCycler® MRSA Advanced Test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) for clinical use in the United States...

Ecolab Launches First EPA-Approved, Ready-to-Use Hard Surface Disinfectant Effective Against Clostridium Difficile
Ecolab Inc. announced the launch of Virasept™, Ecolab's first ready-to-use (no mixing required) hard surface disinfectant approved by the U.S. Environmental Protection Agency to be effective against Clostridium difficile spores. Clostridium difficile is a highly drug-resistant bacterium that causes diarrhea and severe lower intestinal inflammation, which can be life-threatening...

Researchers Identify What Makes MRSA Lethal
Scientists studying the so-called "superbug" MRSA have identified one of the components responsible for making it so deadly. Staphylococcus aureus is a type of bacteria commonly found on the skin that is relatively harmless unless it gets into the bloodstream, where it can cause blood poisoning and create abscesses in organs such as the heart and brain...

Secret Ingredient That Kills Bacteria Identified In Honey
Sweet news for those looking for new antibiotics: A new research published in the July 2010 print edition of the FASEB Journal explains for the first time how honey kills bacteria...